<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen Y</submitter><funding>Innovative Research Group Project of the National Natural Science Foundation of China</funding><funding>The Mega-Project for National Science and Technology Development under "the 13th Five-Year Plan of China"</funding><funding>Zhejiang Province key research and development plan emergency project</funding><funding>The Mega-Project for National Science and Technology Development under &amp;quot;the 13th Five-Year Plan of China&amp;quot;</funding><pagination>191</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8349604</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Knowledge about the 1-year outcome of COVID-19 is limited. The aim of this study was to follow-up and evaluate lung abnormalities on serial computed tomography (CT) scans in patients with COVID-19 after hospital discharge.&lt;h4>Methods&lt;/h4>A prospective cohort study of patients with COVID-19 from the First Affiliated Hospital, Zhejiang University School of Medicine was conducted, with assessments of chest CT during hospitalization and at 2 weeks, 1 month, 3 months, 6 months, and 1 year after hospital discharge. Risk factors of residual CT opacities and the influence of residual CT abnormalities on pulmonary functions at 1 year were also evaluated.&lt;h4>Results&lt;/h4>A total of 41 patients were followed in this study. Gradual recovery after hospital discharge was confirmed by t</pubmed_abstract><journal>BMC medicine</journal><pubmed_title>One-year follow-up of chest CT findings in patients after SARS-CoV-2 infection.</pubmed_title><pmcid>PMC8349604</pmcid><funding_grant_id>2017ZX10105001</funding_grant_id><funding_grant_id>U20A20343</funding_grant_id><funding_grant_id>2020C03123</funding_grant_id><pubmed_authors>Tao J</pubmed_authors><pubmed_authors>Xu K</pubmed_authors><pubmed_authors>Yu L</pubmed_authors><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Xu M</pubmed_authors><pubmed_authors>Ding C</pubmed_authors><pubmed_authors>Feng X</pubmed_authors><pubmed_authors>Guo W</pubmed_authors><pubmed_authors>Yi P</pubmed_authors><pubmed_authors>Su J</pubmed_authors><pubmed_authors>Ren C</pubmed_authors><pubmed_authors>Li L</pubmed_authors><pubmed_authors>Lang G</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Sheng J</pubmed_authors><pubmed_authors>Xu T</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Shi D</pubmed_authors><pubmed_authors>Wu W</pubmed_authors></additional><is_claimable>false</is_claimable><name>One-year follow-up of chest CT findings in patients after SARS-CoV-2 infection.</name><description>&lt;h4>Background&lt;/h4>Knowledge about the 1-year outcome of COVID-19 is limited. The aim of this study was to follow-up and evaluate lung abnormalities on serial computed tomography (CT) scans in patients with COVID-19 after hospital discharge.&lt;h4>Methods&lt;/h4>A prospective cohort study of patients with COVID-19 from the First Affiliated Hospital, Zhejiang University School of Medicine was conducted, with assessments of chest CT during hospitalization and at 2 weeks, 1 month, 3 months, 6 months, and 1 year after hospital discharge. Risk factors of residual CT opacities and the influence of residual CT abnormalities on pulmonary functions at 1 year were also evaluated.&lt;h4>Results&lt;/h4>A total of 41 patients were followed in this study. Gradual recovery after hospital discharge was confirmed by t</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2025-06-01T02:21:52.408Z</modification><creation>2022-02-11T11:00:25.531Z</creation></dates><accession>S-EPMC8349604</accession><cross_references><pubmed>34365975</pubmed><doi>10.1186/s12916-021-02056-8</doi></cross_references></HashMap>